指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

减重手术围术期营养、代谢及非手术支持的临床实践指南——2019更新:美国临床内分泌医师协会/美国内分泌学会、肥胖学会、美国代谢与减重外科学会、肥胖医学协会和美国麻醉医师学会共同主办的执行摘要

CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS
指南 / 共识 · Endocr Pract · 2019-11-04
一句话结论减重手术对高风险肥胖患者仍是安全有效的干预,围术期管理必须采用团队方式并特别关注营养与代谢问题(AACE等五家学会2019指南)。

该2019更新版临床实践指南由美国临床内分泌医师协会(AACE)、肥胖学会、美国代谢与减重外科学会、肥胖医学协会和美国麻醉医师学会共同委托制定,遵循AACE 2017标准化指南制定方案。基于2013年至今的新证据及专家主观因素对每条推荐进行评估和更新,共85条编号推荐(61条修订、12条新增),其中31条(13%)为A级、42条(17%)为B级、72条(29%)为C级、101条(41%)为D级推荐;共858条引文,证据级别1(最高)81条(9.4%)、2级562条(65.5%)、3级72条(8.4%)、4级(最低)143条(16.7%)。新或更新的主题包括:基于肥胖的慢性疾病并发症中心模型的情境化、基于细微差别的算法/清单辅助手术选择决策、新型减重手术、减重手术后加速康复方案以及当前医疗环境中的成本等后勤问题。结论指出减重手术对高风险肥胖患者仍是安全有效的干预,临床决策应在慢性疾病背景下以证据为基础,围术期护理必须采用团队方式并特别关注营养和代谢问题。

要点

  • 减重手术对高风险肥胖患者仍是安全有效的干预(指南结论)。
  • 围术期护理必须采用团队方式,特别关注营养和代谢问题(指南结论)。
  • 临床决策应在慢性疾病背景下以证据为基础(指南结论)。
  • 85条编号推荐中A级31条(13%)、B级42条(17%)、C级72条(29%)、D级101条(41%)。
  • 858条引文中证据级别1(最高)81条(9.4%)、2级562条(65.5%)、3级72条(8.4%)、4级(最低)143条(16.7%)。

适用人群与场景

  • 接受减重手术的肥胖患者,包括高风险患者。

处置流程与药物剂量

  • 围术期护理必须采用团队方式,特别关注营养和代谢问题(指南结论)。

研究设计与关键结果

  • 指南由AACE、肥胖学会、美国代谢与减重外科学会、肥胖医学协会和美国麻醉医师学会董事会共同委托制定,遵循AACE 2017标准化指南制定方案,基于2013年至今的新证据和专家主观因素对每条推荐进行评估和更新。
  • 共85条编号推荐(61条修订、12条新增);单条编号推荐内可含多条推荐声明时,A级31条(13%)、B级42条(17%)、C级72条(29%)、D级101条(41%)。
  • 共858条引文,证据级别1(最高)81条(9.4%)、2级562条(65.5%)、3级72条(8.4%)、4级(最低)143条(16.7%)。
  • 新或更新的主题包括:基于肥胖的慢性疾病并发症中心模型的情境化、基于细微差别的算法/清单辅助手术选择决策、新型减重手术、减重手术后加速康复方案以及当前医疗环境中的成本等后勤问题。

证据类型、等级与局限

  • 证据类型:临床实践指南(指南/共识),由AACE等五家学会共同主办,遵循AACE 2017标准化指南制定方案。
  • 推荐分级:A级31条(13%)、B级42条(17%)、C级72条(29%)、D级101条(41%)。
  • 引文证据级别:1级81条(9.4%)、2级562条(65.5%)、3级72条(8.4%)、4级143条(16.7%)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 减重手术对高风险肥胖患者仍是安全有效的干预(指南结论)。
  • 临床决策应在慢性疾病背景下以证据为基础(指南结论)。
  • 围术期护理必须采用团队方式,特别关注营养和代谢问题(指南结论)。

指南或共识出处

  • 指南名称:减重手术围术期营养、代谢及非手术支持的临床实践指南——2019更新(CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE)。
  • 发布机构:美国临床内分泌医师协会(AACE)、美国内分泌学会(ACE)、肥胖学会(TOS)、美国代谢与减重外科学会(ASMBS)、肥胖医学协会(OMA)、美国麻醉医师学会(ASA)。
  • 年份:2019年。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists (AACE), The Obesity Society, American Society of Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPGs, algorithms, and checklists. Methods: Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts. Results: New or updated topics in this CPG include: contextualization in an adiposity-based chronic disease complications-centric model, nuance-based and algorithm/checklist-assisted clinical decision-making about procedure selection, novel bariatric procedures, enhanced recovery after bariatric surgery protocols, and logistical concerns (including cost factors) in the current health-care arena. There are 85 numbered recommendations that have updated supporting evidence, of which 61 are revised and 12 are new. Noting that there can be multiple recommendation statements within a single numbered recommendation, there are 31 (13%) Grade A, 42 (17%) Grade B, 72 (29%) Grade C, and 101 (41%) Grade D recommendations. There are 858 citations, of which 81 (9.4%) are evidence level (EL) 1 (highest), 562 (65.5%) are EL 2, 72 (8.4%) are EL 3, and 143 (16.7%) are EL 4 (lowest). Conclusion: Bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity. Clinical decision-making should be evidence based within the context of a chronic disease. A team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues. A1C = hemoglobin A1c; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACE = American College of Endocrinology; ADA = American Diabetes Association; AHI = Apnea-Hypopnea Index; ASA = American Society of Anesthesiologists; ASMBS = American Society of Metabolic and Bariatric Surgery; BMI = body mass index; BPD = biliopancreatic diversion; BPD/DS = biliopancreatic diversion with duodenal switch; CI = confidence interval; CPAP = continuous positive airway pressure; CPG = clinical practice guideline; CRP = C-reactive protein; CT = computed tomography; CVD = cardiovascular disease; DBCD = dysglycemia-based chronic disease; DS = duodenal switch; DVT = deep venous thrombosis; DXA = dual-energy X-ray absorptiometry; EFA = essential fatty acid; EL = evidence level; EN = enteral nutrition; ERABS = enhanced recovery after bariatric surgery; FDA = U.S. Food and Drug Administration; G4G = Guidelines for Guidelines; GERD = gastroesophageal reflux disease; GI = gastrointestinal; HCP = health-care professional(s); HTN = hypertension; ICU = intensive care unit; IGB = intragastric balloon(s); IV = intravenous; LAGB = laparoscopic adjustable gastric band; LAGBP = laparoscopic adjustable gastric banded plication; LGP = laparoscopic greater curvature (gastric) plication; LRYGB = laparoscopic Roux-en-Y gastric bypass; LSG = laparoscopic sleeve gastrectomy; MetS = metabolic syndrome; NAFLD = nonalcoholic fatty liver disease; NASH = nonalcoholic steatohepatitis; NSAID = nonsteroidal anti-inflammatory drug; OA = osteoarthritis; OAGB = one-anastomosis gastric bypass; OMA = Obesity Medicine Association; OR = odds ratio; ORC = obesity-related complication(s); OSA = obstructive sleep apnea; PE = pulmonary embolism; PN = parenteral nutrition; PRM = pulmonary recruitment maneuver; RCT = randomized controlled trial; RD = registered dietician; RDA = recommended daily allowance; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy; SIBO = small intestinal bacterial overgrowth; TOS = The Obesity Society; TSH = thyroid-stimulating hormone; T1D = type 1 diabetes; T2D = type 2 diabetes; VTE = venous thromboembolism; WE = Wernicke encephalopathy; WHO = World Health Organization.

来源:Endocr Pract,查看原文。版权归原作者所有。

参考来源

  1. Mechanick JI, Apovian C, Brethauer S, et al. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. Endocr Pract. 2019. PMID: 31682518. doi:10.4158/GL-2019-0406

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。